SET/MLL family proteins in hematopoiesis and leukemia
Accumulating recent evidence supports the notion that many enzymes that modify histones are fundamental players in normal hematopoiesis as well as hematologic malignancies, and represent an important new class of drug targets. Histone H3 lysine 4 (H3K4) methylation plays several distinct roles in ge...
Gespeichert in:
Veröffentlicht in: | International Journal of Hematology 2017-01, Vol.105 (1), p.7-16 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 16 |
---|---|
container_issue | 1 |
container_start_page | 7 |
container_title | International Journal of Hematology |
container_volume | 105 |
creator | Yang, Weiwei Ernst, Patricia |
description | Accumulating recent evidence supports the notion that many enzymes that modify histones are fundamental players in normal hematopoiesis as well as hematologic malignancies, and represent an important new class of drug targets. Histone H3 lysine 4 (H3K4) methylation plays several distinct roles in gene expression and is modulated by specific methyltransferases and demethylases. Recent progress has been made clarifying the unique biological roles of the enzymes that carry out H3K4 methylation, yet a detailed understanding of H3K4 methylation states in various genomic contexts and the diverse functions of the enzymes that perform these methylation events is incomplete, but developing rapidly. In this review, we summarize and discuss the general mechanisms of H3K4 methylation, and how the six main enzymes from the SET/MLL family (responsible for H3K4me1/me2/me3) function in hematopoiesis and in hematologic malignancies. |
doi_str_mv | 10.1007/s12185-016-2118-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859486521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1834999013</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-4d2cdd1a9e390e61ddbfb6121df329541b12ac1db29e062118c566f5303f3a4f3</originalsourceid><addsrcrecordid>eNqNkEtPwzAQhC0EoqXwA7igSFy4hHr9jI-oKg8piAPlbDmxAyl5lLg59N_jKAUhJCROe9hvZ2cGoXPA14CxnHsgkPAYg4gJQBInB2gKieAxlZIdoilWhMdcAp6gE-_XGIPETB6jCZFSCclgivjzcjV_TNOoMHVZ7aJN125d2fiobKI3V5ttu2lL50sfmcZGlevfXV2aU3RUmMq7s_2coZfb5WpxH6dPdw-LmzTOObBtzCzJrQWjHFXYCbA2KzIRTNuCEsUZZEBMDjYjymExRMi5EAWnmBbUsILO0NWoG2x99M5vdV363FWVaVzbex3SKxYCE_gHSplSCgMN6OUvdN32XROCDIKcyEQIHCgYqbxrve9coTddWZtupwHroX491q9D_XrwrpNwc7FX7rPa2e-Lr74DQEbAh1Xz6rofr_9U_QSCFYz7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1855278660</pqid></control><display><type>article</type><title>SET/MLL family proteins in hematopoiesis and leukemia</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Yang, Weiwei ; Ernst, Patricia</creator><creatorcontrib>Yang, Weiwei ; Ernst, Patricia</creatorcontrib><description>Accumulating recent evidence supports the notion that many enzymes that modify histones are fundamental players in normal hematopoiesis as well as hematologic malignancies, and represent an important new class of drug targets. Histone H3 lysine 4 (H3K4) methylation plays several distinct roles in gene expression and is modulated by specific methyltransferases and demethylases. Recent progress has been made clarifying the unique biological roles of the enzymes that carry out H3K4 methylation, yet a detailed understanding of H3K4 methylation states in various genomic contexts and the diverse functions of the enzymes that perform these methylation events is incomplete, but developing rapidly. In this review, we summarize and discuss the general mechanisms of H3K4 methylation, and how the six main enzymes from the SET/MLL family (responsible for H3K4me1/me2/me3) function in hematopoiesis and in hematologic malignancies.</description><identifier>ISSN: 0925-5710</identifier><identifier>EISSN: 1865-3774</identifier><identifier>DOI: 10.1007/s12185-016-2118-8</identifier><identifier>PMID: 27796741</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Animals ; Hematology ; Hematopoiesis ; Histone Chaperones - metabolism ; Histone-Lysine N-Methyltransferase - metabolism ; Histones - metabolism ; Humans ; Leukemia - metabolism ; Leukemia - pathology ; Medicine ; Medicine & Public Health ; Methylation ; Myeloid-Lymphoid Leukemia Protein - metabolism ; Oncology ; Progress in Hematology ; Protein Interaction Maps ; Transcription Factors - metabolism</subject><ispartof>International Journal of Hematology, 2017-01, Vol.105 (1), p.7-16</ispartof><rights>The Japanese Society of Hematology (outside the USA) 2016</rights><rights>International Journal of Hematology is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-4d2cdd1a9e390e61ddbfb6121df329541b12ac1db29e062118c566f5303f3a4f3</citedby><cites>FETCH-LOGICAL-c514t-4d2cdd1a9e390e61ddbfb6121df329541b12ac1db29e062118c566f5303f3a4f3</cites><orcidid>0000-0001-7638-2939</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12185-016-2118-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12185-016-2118-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>313,314,780,784,792,27922,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27796741$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Weiwei</creatorcontrib><creatorcontrib>Ernst, Patricia</creatorcontrib><title>SET/MLL family proteins in hematopoiesis and leukemia</title><title>International Journal of Hematology</title><addtitle>Int J Hematol</addtitle><addtitle>Int J Hematol</addtitle><description>Accumulating recent evidence supports the notion that many enzymes that modify histones are fundamental players in normal hematopoiesis as well as hematologic malignancies, and represent an important new class of drug targets. Histone H3 lysine 4 (H3K4) methylation plays several distinct roles in gene expression and is modulated by specific methyltransferases and demethylases. Recent progress has been made clarifying the unique biological roles of the enzymes that carry out H3K4 methylation, yet a detailed understanding of H3K4 methylation states in various genomic contexts and the diverse functions of the enzymes that perform these methylation events is incomplete, but developing rapidly. In this review, we summarize and discuss the general mechanisms of H3K4 methylation, and how the six main enzymes from the SET/MLL family (responsible for H3K4me1/me2/me3) function in hematopoiesis and in hematologic malignancies.</description><subject>Animals</subject><subject>Hematology</subject><subject>Hematopoiesis</subject><subject>Histone Chaperones - metabolism</subject><subject>Histone-Lysine N-Methyltransferase - metabolism</subject><subject>Histones - metabolism</subject><subject>Humans</subject><subject>Leukemia - metabolism</subject><subject>Leukemia - pathology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methylation</subject><subject>Myeloid-Lymphoid Leukemia Protein - metabolism</subject><subject>Oncology</subject><subject>Progress in Hematology</subject><subject>Protein Interaction Maps</subject><subject>Transcription Factors - metabolism</subject><issn>0925-5710</issn><issn>1865-3774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkEtPwzAQhC0EoqXwA7igSFy4hHr9jI-oKg8piAPlbDmxAyl5lLg59N_jKAUhJCROe9hvZ2cGoXPA14CxnHsgkPAYg4gJQBInB2gKieAxlZIdoilWhMdcAp6gE-_XGIPETB6jCZFSCclgivjzcjV_TNOoMHVZ7aJN125d2fiobKI3V5ttu2lL50sfmcZGlevfXV2aU3RUmMq7s_2coZfb5WpxH6dPdw-LmzTOObBtzCzJrQWjHFXYCbA2KzIRTNuCEsUZZEBMDjYjymExRMi5EAWnmBbUsILO0NWoG2x99M5vdV363FWVaVzbex3SKxYCE_gHSplSCgMN6OUvdN32XROCDIKcyEQIHCgYqbxrve9coTddWZtupwHroX491q9D_XrwrpNwc7FX7rPa2e-Lr74DQEbAh1Xz6rofr_9U_QSCFYz7</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Yang, Weiwei</creator><creator>Ernst, Patricia</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7638-2939</orcidid></search><sort><creationdate>20170101</creationdate><title>SET/MLL family proteins in hematopoiesis and leukemia</title><author>Yang, Weiwei ; Ernst, Patricia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-4d2cdd1a9e390e61ddbfb6121df329541b12ac1db29e062118c566f5303f3a4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Hematology</topic><topic>Hematopoiesis</topic><topic>Histone Chaperones - metabolism</topic><topic>Histone-Lysine N-Methyltransferase - metabolism</topic><topic>Histones - metabolism</topic><topic>Humans</topic><topic>Leukemia - metabolism</topic><topic>Leukemia - pathology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methylation</topic><topic>Myeloid-Lymphoid Leukemia Protein - metabolism</topic><topic>Oncology</topic><topic>Progress in Hematology</topic><topic>Protein Interaction Maps</topic><topic>Transcription Factors - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Weiwei</creatorcontrib><creatorcontrib>Ernst, Patricia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International Journal of Hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Weiwei</au><au>Ernst, Patricia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SET/MLL family proteins in hematopoiesis and leukemia</atitle><jtitle>International Journal of Hematology</jtitle><stitle>Int J Hematol</stitle><addtitle>Int J Hematol</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>105</volume><issue>1</issue><spage>7</spage><epage>16</epage><pages>7-16</pages><issn>0925-5710</issn><eissn>1865-3774</eissn><abstract>Accumulating recent evidence supports the notion that many enzymes that modify histones are fundamental players in normal hematopoiesis as well as hematologic malignancies, and represent an important new class of drug targets. Histone H3 lysine 4 (H3K4) methylation plays several distinct roles in gene expression and is modulated by specific methyltransferases and demethylases. Recent progress has been made clarifying the unique biological roles of the enzymes that carry out H3K4 methylation, yet a detailed understanding of H3K4 methylation states in various genomic contexts and the diverse functions of the enzymes that perform these methylation events is incomplete, but developing rapidly. In this review, we summarize and discuss the general mechanisms of H3K4 methylation, and how the six main enzymes from the SET/MLL family (responsible for H3K4me1/me2/me3) function in hematopoiesis and in hematologic malignancies.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>27796741</pmid><doi>10.1007/s12185-016-2118-8</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-7638-2939</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0925-5710 |
ispartof | International Journal of Hematology, 2017-01, Vol.105 (1), p.7-16 |
issn | 0925-5710 1865-3774 |
language | eng |
recordid | cdi_proquest_miscellaneous_1859486521 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Hematology Hematopoiesis Histone Chaperones - metabolism Histone-Lysine N-Methyltransferase - metabolism Histones - metabolism Humans Leukemia - metabolism Leukemia - pathology Medicine Medicine & Public Health Methylation Myeloid-Lymphoid Leukemia Protein - metabolism Oncology Progress in Hematology Protein Interaction Maps Transcription Factors - metabolism |
title | SET/MLL family proteins in hematopoiesis and leukemia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A20%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SET/MLL%20family%20proteins%20in%20hematopoiesis%20and%20leukemia&rft.jtitle=International%20Journal%20of%20Hematology&rft.au=Yang,%20Weiwei&rft.date=2017-01-01&rft.volume=105&rft.issue=1&rft.spage=7&rft.epage=16&rft.pages=7-16&rft.issn=0925-5710&rft.eissn=1865-3774&rft_id=info:doi/10.1007/s12185-016-2118-8&rft_dat=%3Cproquest_cross%3E1834999013%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1855278660&rft_id=info:pmid/27796741&rfr_iscdi=true |